24 May 2013
Keywords: german, post-vioxx, warning, cox-2s, wake, merck, co
Article | 20 December 2004
In the wake of Merck & Co's withdrawal of Vioxx (rofecoxib; Marketletters passim), the major German drug regulatory and research
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 December 2004
20 December 2004
23 May 2013
© 2013 thepharmaletter.com